tiprankstipranks
Tourmaline Bio might see weakness today after Roche MG data, says Truist
PremiumThe FlyTourmaline Bio might see weakness today after Roche MG data, says Truist
29d ago
Immunovant rallies after Chugai myasthenia gravis study failure
PremiumThe Fly
Immunovant rallies after Chugai myasthenia gravis study failure
29d ago
Immunovant initiated with a Buy at Goldman Sachs
PremiumThe Fly
Immunovant initiated with a Buy at Goldman Sachs
1M ago
Immunovant initiated with an Outperform at Wolfe Research
PremiumThe FlyImmunovant initiated with an Outperform at Wolfe Research
2M ago
Immunovant remains top pick at Citi after year-to-date selloff
PremiumThe Fly
Immunovant remains top pick at Citi after year-to-date selloff
2M ago
Immunovant, Inc. Is Worried About This – Should You Be Worried Too?
PremiumMarket News
Immunovant, Inc. Is Worried About This – Should You Be Worried Too?
2M ago
The biotech stocks to own in 2024, according to Piper Sandler
PremiumThe FlyThe biotech stocks to own in 2024, according to Piper Sandler
4M ago
Immunovant price target raised to $52 from $47 at Stifel
PremiumThe Fly
Immunovant price target raised to $52 from $47 at Stifel
4M ago
Immunovant price target raised to $51 from $49 at BofA
PremiumThe Fly
Immunovant price target raised to $51 from $49 at BofA
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100